The U.S. will soon send its unused AstraZeneca COVID-19 vaccines around the world

Signs indicating Oxford-AstraZeneca vaccines are out of stock in India.
(Image credit: INDRANIL MUKHERJEE/AFP via Getty Images)

The United States will soon begin sharing its entire supply of COVID-19 vaccines developed by AstraZeneca and the University of Oxford, the White House told The Associated Press on Monday.

The Oxford-AstraZeneca vaccine has not been granted emergency use authorization by the Food and Drug Administration yet, but White House COVID-19 coordinator Jeff Zients said the country doesn't need the supply at this point, anyway, given "the strong portfolio of vaccines" already available in the country. That includes the shots developed by Johnson & Johnson, Moderna, and Pfizer and BioNTech.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Tim O'Donnell

Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.